Citigroup’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-75
Closed -$1K 6032
2022
Q2
$1K Buy
+75
New +$656 ﹤0.01% 6031
2017
Q2
Sell
-377
Closed -$5K 7395
2017
Q1
$5K Hold
377
﹤0.01% 6778
2016
Q4
$5K Sell
377
-3,071
-89% -$46.5K ﹤0.01% 6912
2016
Q3
$56K Sell
3,448
-3,100
-47% -$51.1K ﹤0.01% 5594
2016
Q2
$104K Sell
6,548
-2,120
-24% -$37.4K ﹤0.01% 5048
2016
Q1
$219K Buy
8,668
+1,722
+25% +$52.9K ﹤0.01% 4999
2015
Q4
$225K Buy
6,946
+1,697
+32% +$63.5K ﹤0.01% 4635
2015
Q3
$186K Sell
5,249
-5,678
-52% -$256K ﹤0.01% 4558
2015
Q2
$652K Buy
10,927
+7,863
+257% +$529K ﹤0.01% 3467
2015
Q1
$239K Sell
3,064
-7,369
-71% -$570K ﹤0.01% 4367
2014
Q4
$807K Buy
10,433
+7,119
+215% +$465K ﹤0.01% 3363
2014
Q3
$211K Buy
3,314
+882
+36% +$60K ﹤0.01% 4191
2014
Q2
$175K Sell
2,432
-1,661
-41% -$128K ﹤0.01% 4240
2014
Q1
$362K Sell
4,093
-306
-7% -$23.8K ﹤0.01% 3788
2013
Q4
$344K Buy
4,399
+2,309
+110% +$188K ﹤0.01% 4151
2013
Q3
$184K Sell
2,090
-1,885
-47% -$172K ﹤0.01% 4225
2013
Q2
$342K Buy
+3,975
New +$329K ﹤0.01% 3807

Other funds holding HHS

Citigroup's HHS Position: Q3 2022 in Review

Citigroup sold out of Harte-Hanks (HHS) in Q3 2022, closing a stake of 75 shares — an estimated $1K sold.

Citigroup first reported a position in HHS in Q2 2013 and held it in 17 quarters. The position peaked at $807K in Q4 2014. 37 funds tracked by Wall St. Rank hold HHS as of Q3 2022.

  • Citigroup reported no remaining Harte-Hanks position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 75 Harte-Hanks shares in Q3 2022, an estimated $1K.
  • Citigroup first reported a position in Harte-Hanks in Q2 2013 and held it in 17 quarters.
  • Citigroup's Harte-Hanks position peaked at $807K in Q4 2014.
  • 37 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.